ML-SYS / 2026.07NON-CLINICAL RESEARCH MATERIALSORIGIN DECLARED BY LOT

← Compound index

RM-TRS / Tissue, repair and matrix signalling

SYN-AKE

Also known as: Dipeptide Diaminobutyroyl Benzylamide Diacetate · beta-Ala-Pro-Dab-NHBn diacetate

Human evidenceEvidence grade B: Human evidence

Grade describes the published research on the molecule. It is not a quality score, a safety score, or a release state.

What this is

SYN-AKE is a defined synthetic diacetate ingredient. It was designed by analogy to a venom-peptide effect, but it is not Waglerin-1 and does not contain venom.

Evidence position

Small human topical research supports a limited Grade B. The evidence remains tied to defined formulations.

What the record does not establish

The literature does not validate a raw supplier lot, an injectable route or equivalence across concentrations and salt forms.

Sources

  • 01
    SYN-AKE diacetate compound recordPubChem
    Shows
    Registry identity, salt composition, formula and synonyms
    Does not show
    Registry identity does not establish topical performance
  • 02
    Facial-expression wrinkle studyInternational Journal of Peptide Research and Therapeutics
    Shows
    Peer-reviewed study directly discussing the marketed SYN-AKE ingredient
    Does not show
    Small cosmetic study; formulation and commercial relationships limit generalization
  • 03
    SYN-AKE market listingCore Peptides
    Shows
    Current research-market use of the SYN-AKE name
    Does not show
    Supplier copy is not independent evidence or lot verification

External database index

LIVE DATABASE INDEX / SEPARATE FROM CURATED EVIDENCE

Records below come directly from public scientific databases. They help find relevant material, but do not affect the evidence grade until they are matched to the molecule and added to the curated source list.

PUBCHEM / IDENTITY

Dipeptide diaminobutyroyl benzylamide diacetate

CID
71465152
Formula
C23H37N5O7
Mass
495.6
Open identity record ↗

Related compounds